Log In
BCIQ
Print this Print this
 

YM758

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionVoltage-gated ion channel blocker
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAngina
Indication DetailsTreat stable angina
Regulatory Designation
PartnerCardeus Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/04/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today